DudeDiligence.

Crinetics Pharmaceuticals Inc

CRNXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$361,000Mar ’25$1.0MJun ’25$143,000Sep ’25$6.2MDec ’25$10.7MMar ’26$25.1MJun ’26
Net income, by quarter
−$76.8MSep ’24−$80.6MDec ’24−$96.8MMar ’25−$115.6MJun ’25−$130.1MSep ’25−$122.8MDec ’25−$127.8MMar ’26−$120.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.1M$4.7M$4.0M$1.0M$7.7M
Gross profitnone on filenone on file$4.0M$1.0M$6.6M
Operating income−$107.7M−$167.9M−$222.6M−$338.9M−$516.8M
Net income−$107.6M−$163.9M−$214.5M−$298.4M−$465.3M
Operating cash flow−$88.6M−$115.2M−$168.6M−$230.2M−$377.9M
Free cash flow−$89.0M−$116.9M−$173.3M−$234.0M−$383.7M
Cash$200.7M$32.7M$54.9M$264.5M$101.5M
Shares outstanding47.6M53.9M68.2M92.9M95.6M